Cargando…

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis

BACKGROUND: Rifampicin resistant tuberculosis remains a global health problem with almost half a million new cases annually. In high-income countries patients empirically start a standardized treatment regimen, followed by an individualized regimen guided by drug susceptibility test (DST) results. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verboven, Lennert, Callens, Steven, Black, John, Maartens, Gary, Dooley, Kelly E., Potgieter, Samantha, Cartuyvels, Ruben, Laukens, Kris, Warren, Robin M., Van Rie, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949242/ https://www.ncbi.nlm.nih.gov/pubmed/36824956 http://dx.doi.org/10.21203/rs.3.rs-2525765/v1

Ejemplares similares

A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2023)

Comprehensive and accurate genetic variant identification from contaminated and low-coverage Mycobacterium tuberculosis whole genome sequencing data
por: Heupink, Tim H., et al.
Publicado: (2021)

The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples
por: Heupink, Tim H., et al.
Publicado: (2023)

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2022)

Nanopore Sequencing for Mycobacterium tuberculosis: a Critical Review of the Literature, New Developments, and Future Opportunities
por: Dippenaar, Anzaan, et al.
Publicado: (2022)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes
por: Katende, Bulemba, et al.
Publicado: (2020)

MESSAR: Automated recommendation of metabolite substructures from tandem mass spectra
por: Liu, Youzhong, et al.
Publicado: (2020)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
por: Van Rie, Annelies, et al.
Publicado: (2022)

Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study
por: Tu, Pham Hien Trang, et al.
Publicado: (2022)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
por: De Vos, Elise, et al.
Publicado: (2023)

Isoniazid and Rifampicin Resistance-Conferring Mutations in Mycobacterium tuberculosis Isolates from South Africa
por: Traoré, Afsatou Ndama, et al.
Publicado: (2023)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization–Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid
por: David, Anura, et al.
Publicado: (2023)

The Safety, Effectiveness and Concentrations of Adjusted Lopinavir/Ritonavir in HIV-Infected Adults on Rifampicin-Based Antitubercular Therapy
por: Decloedt, Eric H., et al.
Publicado: (2012)

Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB(®) Assay
por: Ok, Vichita, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Rifampicin-induced nephrotoxicity in a tuberculosis patient
por: Beebe, Alexandria, et al.
Publicado: (2015)

Chylothorax in a child with rifampicin-resistant tuberculosis
por: McLaren, B, et al.
Publicado: (2019)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Navigating a Path to Rifampicin Resistance in Tuberculosis
por: Agarwal, Sakshi, et al.
Publicado: (2023)

Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis
por: Bouton, Tara C., et al.
Publicado: (2019)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
por: Feliciano, Cinara Silva, et al.
Publicado: (2019)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
por: Paulauskienė, Iveta, et al.
Publicado: (2016)

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
por: Zhang, C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bm5vr9bh6haol200npbmeridsr